BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 25017584)

  • 1. Evaluation of various active surveillance protocols in prostate cancer.
    Yılmaz K; Karadeniz T; Ozkaptan O; Yilanoglu O
    Arch Ital Urol Androl; 2014 Jun; 86(2):81-5. PubMed ID: 25017584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary Gleason pattern upgrading in contemporary patients with D'Amico low-risk prostate cancer: implications for future biomarkers and imaging modalities.
    Leyh-Bannurah SR; Abou-Haidar H; Dell'Oglio P; Schiffmann J; Tian Z; Heinzer H; Huland H; Graefen M; Budäus L; Karakiewicz PI
    BJU Int; 2017 May; 119(5):692-699. PubMed ID: 27367469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing D'Amico risk groups in radical prostatectomy through the addition of magnetic resonance imaging data.
    Algarra R; Zudaire B; Tienza A; Velis JM; Rincón A; Pascual I; Zudaire J
    Actas Urol Esp; 2014 Nov; 38(9):594-9. PubMed ID: 24791621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of the Biochemical Recurrence risk between Radical Prostatectomy and Brachytherapy in the treatment of low- and intermediate-risk prostate cancer].
    Martínez PF; Belisle DF; Cristallo C; Tobía I; Damia O; Villamil W; Giudice CR
    Arch Esp Urol; 2015 Oct; 68(8):655-60. PubMed ID: 26437328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposal of a new nomogram for predicting upstaging in contemporary D'Amico low-risk prostate cancer patients.
    Leyh-Bannurah SR; Dell'Oglio P; Tian Z; Schiffmann J; Shariat SF; Suardi N; Francesco M; Alberto B; Heinzer H; Huland H; Graefen M; Budäus L; Karakiewicz PI
    World J Urol; 2017 Feb; 35(2):189-197. PubMed ID: 27289238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reassessment of the risk factors for biochemical recurrence in D'Amico intermediate-risk prostate cancer treated using radical prostatectomy.
    Narita S; Mitsuzuka K; Tsuchiya N; Koie T; Kawamura S; Ohyama C; Tochigi T; Yamaguchi T; Arai Y; Habuchi T;
    Int J Urol; 2015 Nov; 22(11):1029-35. PubMed ID: 26290306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncological outcomes in patients potentially eligible for active surveillance who underwent radical prostatectomy.
    Blázquez C; Hernández V; de la Peña E; Díaz FJ; Martin MD; de la Morena JM; Llorente C
    Actas Urol Esp; 2013; 37(10):603-7. PubMed ID: 23850164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of D'Amico criteria for low-risk prostate cancer.
    Milonas D; Kinčius M; Skulčius G; Matjošaitis AJ; GudinavičienĖ I; Jievaltas M
    Scand J Urol; 2014 Aug; 48(4):344-9. PubMed ID: 24521187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is clinical stage T2c prostate cancer an intermediate- or high-risk disease?
    Klaassen Z; Singh AA; Howard LE; Feng Z; Trock B; Terris MK; Aronson WJ; Cooperberg MR; Amling CL; Kane CJ; Partin A; Han M; Freedland SJ
    Cancer; 2015 May; 121(9):1414-21. PubMed ID: 25492369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.
    Vellekoop A; Loeb S; Folkvaljon Y; Stattin P
    J Urol; 2014 Feb; 191(2):350-7. PubMed ID: 24071481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Factors Associated With Pathological Grade Group 1 Patients in D'Amico Intermediate-Risk Group Following Robot-Assisted Radical Prostatectomy: A Retrospective Multicenter Cohort Study in Japan (The MSUG94 Group).
    Sugino Y; Sasaki T; Ebara S; Tatenuma T; Ikehata Y; Nakayama A; Kawase M; Toide M; Yoneda T; Sakaguchi K; Teishima J; Makiyama K; Kitamura H; Saito K; Koie T; Koga F; Urakami S; Inoue T
    Clin Genitourin Cancer; 2022 Dec; 20(6):593-600. PubMed ID: 35773146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delay of surgery in men with low risk prostate cancer.
    O'Brien D; Loeb S; Carvalhal GF; McGuire BB; Kan D; Hofer MD; Casey JT; Helfand BT; Catalona WJ
    J Urol; 2011 Jun; 185(6):2143-7. PubMed ID: 21496847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of prostate-specific antigen biochemical recurrence in patients undergoing primary whole-gland prostate cryoablation.
    Liu YY; Chiang PH; Chuang YC; Lee WC; Cheng YT; Wang HJ
    Ann Surg Oncol; 2015 May; 22(5):1612-7. PubMed ID: 25287436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of unfavorable disease after radical prostatectomy in patients at low risk by D'Amico criteria: role of multiparametric magnetic resonance imaging.
    Song SH; Pak S; Park S; Song C; Jeong IG; Choi HJ; Kim JK; Cho KS; Kim CS; Ahn H
    J Urol; 2014 Aug; 192(2):402-8. PubMed ID: 24631106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
    Suardi N; Capitanio U; Chun FK; Graefen M; Perrotte P; Schlomm T; Haese A; Huland H; Erbersdobler A; Montorsi F; Karakiewicz PI
    Cancer; 2008 Oct; 113(8):2068-72. PubMed ID: 18792067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [High-risk prostate cancer surgical margins during robot-assisted radical prostatectomy].
    Duperron C; Moulin M; Koutlidis N; Mourey E; Cormier L
    Prog Urol; 2015 Jun; 25(7):390-5. PubMed ID: 25759079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
    Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
    J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary evaluation of the D'amico risk classification of prostate cancer.
    Hernandez DJ; Nielsen ME; Han M; Partin AW
    Urology; 2007 Nov; 70(5):931-5. PubMed ID: 18068450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
    Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bias due to missing SEER data in D'Amico risk stratification of prostate cancer.
    Elliott SP; Johnson DP; Jarosek SL; Konety BR; Adejoro OO; Virnig BA
    J Urol; 2012 Jun; 187(6):2026-31. PubMed ID: 22498210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.